MedCare’s Free Weight Loss Consultation for Mounjaro is designed to work like a structured clinical intake: you select your option, complete a multi-step questionnaire (shown as “Step 1 of 31”), upload verification, and your answers are reviewed by a clinician before any prescription decision is made.

This page breaks down what MedCare asks and why so users understand the logic instead of feeling like it’s “too many questions”.

If you want the product hub first, start here: Mounjaro weight loss injection pen.

Table of Contents

Quick overview: what happens after you click “Free Consultation”

On the Mounjaro product page, MedCare states the process as:
Choose option → fill in consultation → add to basket → checkout.

Inside the form, MedCare clarifies:

it is an online consultation similar to a traditional one,
your answers are important for suitability,
and the answers are read by a clinician.

MedCare also notes you may be contacted by phone or video call if needed to ensure the medicine is suitable.

Step-by-step: MedCare consultation flow (new vs repeat)

1) New customer vs repeat customer

The very first decision is whether you’re:

New (not previously prescribed weight loss treatment by MedCare; includes transfers), or
Repeat (already prescribed by MedCare and requesting continuation).

Why it matters: repeat customers need “change detection” (what changed since last review), while new customers need full baseline screening.

2) Acknowledgement + lifestyle requirement

MedCare asks you to confirm you understand:

you’ll be asked for full medical history/symptoms,
lifestyle change is vital for sustained weight loss.

What you’ll need before starting (quick checklist)

A current full-body photo that verifies the date (paper with today’s date)
A clear photo on scales showing the weight reading and full body
Photo ID for identity verification
Your height and weight (cm / kg)
Your current medicines list
Your GP surgery details (name/address/postcode)

Verification uploads (ID + dated scales photo) – why it’s required

MedCare explicitly requires uploads:

“upload a current full body picture verifying the date” (with a paper showing today’s date),
and “upload your I.D”.

Later in the form, MedCare is even more specific:

upload a clear full-body photo standing on weighing scales,
full body and the weight reading must be visible,
include a paper with today’s date,
and states it’s visible only to the prescriber and needed before processing the order.

MedCare also describes this as private and GDPR/ICO compliant within the upload instructions.
And on the general Weight Management page, MedCare lists verification steps:
photo + date note, and a photo showing weight on scales.

Why this exists (UK market reality):
UK pharmacy regulators have tightened expectations around supply of weight-loss injections, including independent verification of height/weight/BMI rather than relying only on a questionnaire.

BMI + ethnicity questions – why they exist

MedCare asks for:

sex,
ethnicity group,
and explains why: certain ethnic backgrounds have increased risk at lower BMI and may be eligible at a lower BMI.

Why it matters clinically:
NICE and NHS implementation documents recognise BMI thresholds can be adjusted (commonly −2.5 kg/m²) for some ethnic groups because cardiometabolic risk occurs at lower BMI.

MedCare then asks for:

Weight (kg) and Height (cm) explicitly “to calculate BMI.”

Medical screening questions – what MedCare checks

MedCare’s form asks whether you’ve used weight-loss injections before (e.g., Mounjaro/Wegovy/Ozempic etc.), and if yes, requests dose/date/starting weight and pen usage.

Then MedCare includes a screening list of conditions, including:

acromegaly/growth hormone problems
current cancer
Cushing’s syndrome
eating disorders (current/previous)
gallbladder/bile duct problems or pancreatitis
heart failure
inflammatory bowel disease or gastroparesis
kidney disease
liver disease
multiple endocrine neoplasia (MEN)
personal or family history of medullary thyroid cancer
type 1 diabetes or diabetic retinopathy

Why these are asked (high level):
These conditions can change whether the medicine is safe, whether side-effects risk is higher, or whether a patient needs a different pathway (specialist input, different treatment choice, or “not suitable”).

Medication + pregnancy/breastfeeding checks

MedCare asks if any apply:

trying to conceive,
pregnant/intending pregnancy,
breastfeeding or planning to breastfeed.

MedCare also asks about:

prescription-only medicines,
OTC medicines,
alternative medicines,
recreational drugs.

Why this matters: interactions and safety (and pregnancy/breastfeeding are common exclusion zones for weight-loss injections).

Safe-use agreements (dose rules, don’t combine meds, red flags)

MedCare includes explicit patient agreements such as:

inject once weekly,
don’t start at higher dose,
dose escalation should be at least 4 weeks per dose,
don’t take other weight-loss drugs at the same time,
and what to do with missed doses (including restarting logic).

MedCare also includes red-flag symptom advice:

possible increased risk of pancreatitis/gallbladder problems; abdominal pain → seek advice,
neck lumps/hoarse voice → stop and speak to doctor,
mood lowering/depression → stop and speak to doctor.

Why this is included: to create informed consent and reduce preventable harm from incorrect dosing, mixing treatments, or ignoring red flags.

GP notification consent is mandatory – why coordinated care matters

MedCare states:

patients should inform their GP of any treatment provided,
consent to notify your GP is must ,

Why MedCare does this:
It reduces risk from duplicate prescribing, missed interactions, and gaps in medical records-especially important for weight-loss injections that can affect other conditions and medicines.

What happens if you’re not suitable?

MedCare’s agreement text makes the decision model clear:

the treatment decision is joint, but final approval rests with the prescriber,
if unsuitable, you’ll be directed to alternative care.

Also, MedCare notes they may need to contact you by phone/video to ensure suitability and orders may be delayed if they can’t reach you when needed.

“Why so strict?” The wider UK context (remote prescribing safeguards)

UK medical regulators highlight safeguards needed for remote prescribing and online supply, including adequate assessment and patient dialogue.
And UK pharmacy regulator changes for weight-loss injections have focused on stronger verification practices rather than questionnaire-only supply.

This is why MedCare’s process includes:
verification uploads + clinician review + possible phone/video escalation.